Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 12497 | 838 | 32.2 | 46% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 782 | 11545 | CARDIOPLEGIA//JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY//CARIPORIDE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | GLYCEROL OUTPUT | Author keyword | 6 | 100% | 0% | 4 |
| 2 | OXFENICINE | Author keyword | 3 | 38% | 1% | 6 |
| 3 | METHYLPALMOXIRATE | Author keyword | 3 | 50% | 0% | 4 |
| 4 | PALMITOYL CARNITINE | Author keyword | 2 | 44% | 0% | 4 |
| 5 | L PALMITOYLCARNITINE | Author keyword | 2 | 67% | 0% | 2 |
| 6 | PALMITOYLCARNITINE | Author keyword | 2 | 27% | 1% | 7 |
| 7 | DILAZEP | Author keyword | 2 | 23% | 1% | 8 |
| 8 | POCA | Author keyword | 2 | 43% | 0% | 3 |
| 9 | ANTI ISCHEMIC DRUGS | Author keyword | 1 | 50% | 0% | 2 |
| 10 | K 7259 | Author keyword | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | GLYCEROL OUTPUT | 6 | 100% | 0% | 4 | Search GLYCEROL+OUTPUT | Search GLYCEROL+OUTPUT |
| 2 | OXFENICINE | 3 | 38% | 1% | 6 | Search OXFENICINE | Search OXFENICINE |
| 3 | METHYLPALMOXIRATE | 3 | 50% | 0% | 4 | Search METHYLPALMOXIRATE | Search METHYLPALMOXIRATE |
| 4 | PALMITOYL CARNITINE | 2 | 44% | 0% | 4 | Search PALMITOYL+CARNITINE | Search PALMITOYL+CARNITINE |
| 5 | L PALMITOYLCARNITINE | 2 | 67% | 0% | 2 | Search L+PALMITOYLCARNITINE | Search L+PALMITOYLCARNITINE |
| 6 | PALMITOYLCARNITINE | 2 | 27% | 1% | 7 | Search PALMITOYLCARNITINE | Search PALMITOYLCARNITINE |
| 7 | DILAZEP | 2 | 23% | 1% | 8 | Search DILAZEP | Search DILAZEP |
| 8 | POCA | 2 | 43% | 0% | 3 | Search POCA | Search POCA |
| 9 | ANTI ISCHEMIC DRUGS | 1 | 50% | 0% | 2 | Search ANTI+ISCHEMIC+DRUGS | Search ANTI+ISCHEMIC+DRUGS |
| 10 | K 7259 | 1 | 100% | 0% | 2 | Search K+7259 | Search K+7259 |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | LYSOPHOSPHOGLYCERIDES | 33 | 75% | 3% | 24 |
| 2 | LONG CHAIN ACYLCARNITINES | 8 | 52% | 1% | 11 |
| 3 | PALMITYLCARNITINE | 5 | 55% | 1% | 6 |
| 4 | CANINE PURKINJE FIBERS | 4 | 16% | 3% | 24 |
| 5 | ENTRY BLOCKING ACTIVITY | 3 | 100% | 0% | 3 |
| 6 | ISCHEMIC HUMAN MYOCARDIUM | 3 | 60% | 0% | 3 |
| 7 | ACYL CARNITINE | 2 | 44% | 0% | 4 |
| 8 | MEMBRANE DYSFUNCTION | 2 | 32% | 1% | 6 |
| 9 | ANTIISCHEMIC ACTION | 2 | 67% | 0% | 2 |
| 10 | PALMITOYL CARNITINE | 2 | 26% | 1% | 6 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| FATTY-ACID HOMEOSTASIS IN THE NORMOXIC AND ISCHEMIC HEART | 1992 | 292 | 376 | 35% |
| AMPHIPATHIC METABOLITES AND MEMBRANE DYSFUNCTION IN ISCHEMIC MYOCARDIUM | 1984 | 380 | 46 | 54% |
| ROLE OF FATTY-ACID METABOLITES IN THE DEVELOPMENT OF MYOCARDIAL ISCHEMIC DAMAGE | 1992 | 20 | 31 | 61% |
| K-7259: A cardioprotective derivative of dilazep | 1997 | 1 | 41 | 76% |
| PURIFICATION OF LYSOPHOSPHOLIPASE AND LYSOPHOSPHOLIPASE-TRANSACYLASE FROM RABBIT MYOCARDIUM | 1991 | 3 | 6 | 100% |
| Regulation of myocardial triacylglycerol synthesis and metabolism | 2003 | 26 | 119 | 16% |
| Acylcarnitines-old actors auditioning for new roles in metabolic physiology | 2015 | 0 | 80 | 21% |
| Alterations in myocardial lipid metabolism during myocardial ischemia and reperfusion | 2002 | 19 | 165 | 12% |
| Molecular and genetic aspects of cardiac fatty acid homeostasis in health and disease | 2002 | 3 | 118 | 20% |
| LIPID-MEMBRANE INTERACTIONS AND THE PATHOGENESIS OF ISCHEMIC DAMAGE IN THE MYOCARDIUM | 1981 | 592 | 8 | 25% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PROSIVAD | 1 | 27% | 0.5% | 4 |
| 2 | 2 BEAUMONT ST | 1 | 50% | 0.1% | 1 |
| 3 | 333 W 10TH AVE | 1 | 50% | 0.1% | 1 |
| 4 | EN MESHALKIN CIRCULATORY DIS | 1 | 50% | 0.1% | 1 |
| 5 | HLTH CARDIOL | 1 | 50% | 0.1% | 1 |
| 6 | HLTH MED CARDIOL | 1 | 50% | 0.1% | 1 |
| 7 | MED CARDIAC ELE OPHYSIOL S | 1 | 50% | 0.1% | 1 |
| 8 | MED PHYSIOL CHEM5170 GRAVES HALL | 1 | 50% | 0.1% | 1 |
| 9 | MOLEC BIOL PADUALAAN 8 | 1 | 50% | 0.1% | 1 |
| 10 | PHARMACOL INTERNAL MED CARDIOL | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000156232 | CALCIUM PARADOX//2 3 BUTANEDIONE MONOXIME//CREATINE KINASE RELEASE |
| 2 | 0.0000148141 | MILDRONATE//MET 88//GAMMA BUTYROBETAINE HYDROXYLASE INHIBITOR |
| 3 | 0.0000131902 | H 3DIHYDROALPRENOLOL//PHYSIOPATHOL PHARMACOL CARDIOVASC EXPTL//UNHPI |
| 4 | 0.0000120222 | HYPOXIC HEART DAMAGE//EHF DIELECTROMETRY//NO FLOW PHENOMENON |
| 5 | 0.0000104006 | EXOGENOUS PHOSPHOCREATINE//TARUIS DISEASE//EARLY AUTOPSY |
| 6 | 0.0000103676 | PLASMALOGEN//PLASMALOGENS//PLASMENYLCHOLINE |
| 7 | 0.0000090391 | LYSOPHOSPHATIDYLCHOLINE//G2A//TDAG8 |
| 8 | 0.0000087200 | ANIPAMIL//KINGS CARDIOVASC BIOL MED//S 2150 |
| 9 | 0.0000086146 | ALPHA TOCOPHEROL ANALOG//MYOCARDIAL STUNNING//CORONARY ARTERY REPERFUSION |
| 10 | 0.0000085471 | PROGRAM INTEGRAT CARDIAC METAB//HERITAGE MED 423//CARDIAC METABOLISM |